Tumors cause excessive activation of the PD-1/L1 signaling pathway, which in turn reduces T-cell activation and antigen-specific T-cell immune response, and finally bypasses immune surveillance, thus promoting tumor growth [69, 74, 75]. This evidence concerns the gene PDCD1 and neoplasm.